Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

According to recommendations of the 6th WHO Advisory Committee on Buruli ulcer, directly observed treatment with the combination of rifampin and streptomycin, administered daily for 8 weeks, was recommended to 310 patients diagnosed with Buruli ulcer in Pobè, Bénin. Among the 224 (72%) eligible pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Chauty, Annick, Ardant, Marie-Françoise, Adeye, Ambroise, Euverte, Hélène, Guédénon, Augustin, Johnson, Christian, Aubry, Jacques, Nuermberger, Eric, Grosset, Jacques
Format: Artigo
Language:Inglês
Published: American Society for Microbiology (ASM) 2007
Subjects:
Clinical Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2151409/
https://ncbi.nlm.nih.gov/pubmed/17526760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00175-07
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items